Your browser doesn't support javascript.
loading
Mavorixafor, an Orally Bioavailable CXCR4 Antagonist, Increases Immune Cell Infiltration and Inflammatory Status of Tumor Microenvironment in Patients with Melanoma.
Andtbacka, Robert H I; Wang, Yan; Pierce, Robert H; Campbell, Jean S; Yushak, Melinda; Milhem, Mohammed; Ross, Merrick; Niland, Katie; Arbeit, Robert D; Parasuraman, Sudha; Bickley, Kris; Yeung, Cecilia Cs; Aicher, Lauri D; Smythe, Kimberly S; Gan, Lu.
Affiliation
  • Andtbacka RHI; Surgical Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah.
  • Wang Y; X4 Pharmaceuticals, Boston, Massachusetts.
  • Pierce RH; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Campbell JS; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Yushak M; Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, Georgia.
  • Milhem M; Medical Oncology, University of Iowa, Iowa City, Iowa.
  • Ross M; Surgical Oncology, MD Anderson Cancer Center, University of Texas, Houston, Texas.
  • Niland K; X4 Pharmaceuticals, Boston, Massachusetts.
  • Arbeit RD; X4 Pharmaceuticals, Boston, Massachusetts.
  • Parasuraman S; X4 Pharmaceuticals, Boston, Massachusetts.
  • Bickley K; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Yeung CC; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Aicher LD; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Smythe KS; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Gan L; X4 Pharmaceuticals, Boston, Massachusetts.
Cancer Res Commun ; 2(8): 904-913, 2022 08.
Article de En | MEDLINE | ID: mdl-36923305

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Microenvironnement tumoral / Mélanome Limites: Humans Langue: En Journal: Cancer Res Commun Année: 2022 Type de document: Article Pays de publication: États-Unis d'Amérique

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Microenvironnement tumoral / Mélanome Limites: Humans Langue: En Journal: Cancer Res Commun Année: 2022 Type de document: Article Pays de publication: États-Unis d'Amérique